Further Details to Note about Updated Clinical Lab Director Qualifications
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
Keep up to date on the latest legal, compliance, and business developments affecting the lab industry, while offering analysis and insight to ensure your lab’s success.
Put into place late last year, the new rules place more emphasis on formal and continuing education requirements
$152.1 million SYNLAB deal is expected to create a new channel for Labcorp to market its sophisticated specialty assays
How the current FDA AI/ML device regulations may be impeding innovation in the clinical lab
FDA seems determined to push ahead with final rule, regardless of CDRH director’s departure, hiring of replacement.
CEO Laurie Menser discusses the Association for Molecular Pathology’s court case against the FDA’s rule on laboratory-developed tests.
The most common AI compliance risk areas related to data security and patient privacy, and the current regulatory landscape
Though needed to protect data and patient privacy, some in the industry say that more flexibility is needed
Why ongoing coaching and learning is required for laboratory sales reps—even experienced ones—to help labs meet their business goals
The rounds of funding to Clarapath, PreciseDx, and Precision Epigenomics come at a time when other M&A activity is seasonally slow
Recent government efforts to address increased cyberattacks in the healthcare space, and how your lab could benefit
Though payers’ adoption of AI has made reimbursement more challenging for labs, providers can also use AI to address these issues